Detalhe da pesquisa
1.
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer.
Proc Natl Acad Sci U S A
; 117(2): 1119-1128, 2020 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31888983
2.
Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations.
Cytokine
; 138: 155404, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33360025
3.
Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression.
Carcinogenesis
; 36 Suppl 1: S2-18, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26106139
4.
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.
Carcinogenesis
; 36 Suppl 1: S254-96, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26106142
5.
RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression.
Mol Cancer
; 14: 137, 2015 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26204939
6.
Critical role of the endogenous interferon ligand-receptors in type I and type II interferons response.
Immunology
; 142(3): 442-52, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24597649
7.
Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer.
J Immunother Cancer
; 11(7)2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433716
8.
Interferon lambda: a new sword in cancer immunotherapy.
Clin Dev Immunol
; 2011: 349575, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22190970
9.
Resistance to transforming growth factor ß-mediated tumor suppression in melanoma: are multiple mechanisms in place?
Carcinogenesis
; 31(10): 1710-7, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20656791
10.
Antitumor activity of type I and type III interferons in BNL hepatoma model.
Cancer Immunol Immunother
; 59(7): 1059-71, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20217081
11.
Interferon Lambda: Toward a Dual Role in Cancer.
J Interferon Cytokine Res
; 39(1): 22-29, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30020822
12.
Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma.
Cancer Res
; 66(8): 4468-77, 2006 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16618774
13.
Transcription factors as critical players in melanoma invasiveness, drug resistance, and opportunities for therapeutic drug development.
Pigment Cell Melanoma Res
; 31(2): 241-252, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29090514
14.
IFN-lambda therapy: current status and future perspectives.
Drug Discov Today
; 21(1): 167-171, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26552337
15.
IFN-λ: A New Inducer of Local Immunity against Cancer and Infections.
Front Immunol
; 7: 598, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-28018361
16.
IFN-λ cancer immunotherapy: new kid on the block.
Immunotherapy
; 8(8): 877-88, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27381684
17.
Concerted action of IFN-α and IFN-λ induces local NK cell immunity and halts cancer growth.
Oncotarget
; 7(31): 49259-49267, 2016 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27363032
18.
The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma.
Oncotarget
; 7(20): 29689-707, 2016 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27102439
19.
Non-oncogenic Acute Viral Infections Disrupt Anti-cancer Responses and Lead to Accelerated Cancer-Specific Host Death.
Cell Rep
; 17(4): 957-965, 2016 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27760326
20.
Editorial: Tumor Microenvironment and Resistance to Current Therapies.
Front Oncol
; 9: 1131, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31799174